Conference Coverage

Colorectal Cancer Is Spiking Among Some Young Americans


 

FROM DDW 2024

WASHINGTON — Despite encouraging drops in overall colorectal cancer rates in the past two decades, one group stands out as an exception: Americans younger than 45.

Colorectal cancer cases increased 333% among 15- to 19-year-olds and 185% among 20- to 24-year-olds from 1999 to 2020, according to new research presented at the annual Digestive Disease Week®.

As high as those percentages appear, the number of people affected at these ages remains small compared with rates in Americans 45 and older, said Loren Laine, MD, AGAF, professor of medicine (digestive diseases) at Yale School of Medicine, who co-moderated a news briefing discussing the research.

Dr. Loren Laine, chief of the section of digestive diseases, internal medicine, and medical chief, digestive health, Yale School of Medicine, New Haven, Connecticut

Dr. Loren Laine

“The trends are alarming [but] the actual numbers of colorectal cancer cases among children and teens are not high enough to suggest widespread screening,” agreed lead investigator Islam Mohamed, MD, an internal medicine resident at the University of Missouri-Kansas City.

Dr. Islam Mohamed, internal medicine resident at the University of Missouri-Kansas City

Dr. Islam Mohamed

For example, 1 out of every 333,000 15- to-19-year-olds developed colorectal cancer in 1999. Colorectal cancer became more common by 2020, when 1 out of every 77,000 teens developed it.

At the same time, the number of cases in young adults 20 to 24 increased from less than 1 to 2 per 100,000 in 2020.

Even if the risk is relatively low in terms of absolute numbers, experts are keeping an eye on why the rates are increasing. It’s also about raising awareness. If someone younger than 45 experiences colorectal cancer symptoms like blood in their stool, stomach pain, changes in bowel habits, or others, they should seek medical attention, Dr. Laine said.

“If you have symptoms like rectal bleeding, you shouldn’t take it lightly. It’s still pretty unlikely that they’re going to have colon cancer ... but obviously you should still not totally dismiss it,” Dr. Laine said.

“Colorectal cancer is no longer considered just a disease of the elderly population,” Dr. Mohamed said during the briefing. “It’s important that the public is aware of signs and symptoms of colorectal cancer.”

Dr. Mohamed and colleagues studied colorectal cancer cases using numbers from the CDC Wonder Database, a central database of public health information. They calculated increases by comparing rates in 1999 to 2020.

Colorectal cancer is a major cause of cancer-related death in the United States. It currently ranks third in terms of new cases and cancer-related deaths once some skin cancers are excluded, American Cancer Society data indicates.

Some Risk Factors Can Be Changed

The colorectal cancer rates in younger people “have been consistently rising. It might be related to the environmental factors, lifestyle factors, and genetic factors as well,” Dr. Mohamed said. “It also might mean that we are doing better. Maybe we’re screening patients more, and maybe we’re doing a greater job of picking patients who are at high risk of colorectal cancer in the younger population.”

“Adopting a healthy lifestyle would be a great approach to curb the rising incidence of colorectal cancer as we saw metabolic syndrome is a big [factor],” Dr. Mohamed added. Patients should be encouraged to maintain a balanced diet, engage in regular physical activity, and maybe limit alcohol consumption, he said.

On the other hand, up to one third of early-onset colorectal cancer cases are linked to factors that cannot be changed. A family history of colorectal cancer, presence of inflammatory bowel disease, and certain types of cancers linked to genetic mutations are examples. “When you think about it, most of those young people [with colorectal cancer] probably have genetic syndromes,” Dr. Laine said. “The big issue is, frankly, finding better ways to identify families that have genetic syndromes. That’s probably the biggest message.”

Pages

Recommended Reading

Does Bariatric Surgery Increase or Decrease Cancer Risk? It Depends.
MDedge Hematology and Oncology
Cell-Free DNA Blood Test Has High Accuracy for Detecting Colorectal Cancer
MDedge Hematology and Oncology
New CRC stool test beats FIT for sensitivity but not specificity
MDedge Hematology and Oncology
Liquid Biopsy for Colorectal Cancer Appears Promising But Still Lacks Robust Efficacy
MDedge Hematology and Oncology
New Quality Measure Improves Follow-Up for CRC Screening
MDedge Hematology and Oncology
Liquid Biopsy Has Near-Perfect Accuracy for Early Pancreatic Cancer
MDedge Hematology and Oncology
Late-Stage Incidence Rates Support CRC Screening From Age 45
MDedge Hematology and Oncology
Oral Microbiome Test Could Detect Gastric Cancer Earlier
MDedge Hematology and Oncology
FDA OKs First Multitarget Stool RNA Test for CRC Screening
MDedge Hematology and Oncology
Mailed Outreach for CRC Screening Appeals Across Races and Ethnicities
MDedge Hematology and Oncology